Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Minden, Kirsten
2006.
What are the costs of childhood-onset rheumatic disease?.
Best Practice & Research Clinical Rheumatology,
Vol. 20,
Issue. 2,
p.
223.
Kruper, Laura
Kurichi, Jibby E.
and
Sonnad, Seema S.
2007.
Methodologic Quality of Cost-Effectiveness Analyses of Surgical Procedures.
Annals of Surgery,
Vol. 245,
Issue. 1,
p.
147.
Ladapo, Joseph A
Neumann, Peter J
Keren, Ron
and
Prosser, Lisa A
2007.
Valuing Children???s Health.
PharmacoEconomics,
Vol. 25,
Issue. 10,
p.
817.
Prosser, Lisa A
Hammitt, James K
and
Keren, Ron
2007.
Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children.
PharmacoEconomics,
Vol. 25,
Issue. 9,
p.
713.
Au, Flora
Prahardhi, Shirlina
and
Shiell, Alan
2008.
Reliability of Two Instruments for Critical Assessment of Economic Evaluations.
Value in Health,
Vol. 11,
Issue. 3,
p.
435.
Barnett, Paul G.
2009.
An Improved Set of Standards for Finding Cost for Cost-Effectiveness Analysis.
Medical Care,
Vol. 47,
Issue. 7_Supplement_1,
p.
S82.
Tsimicalis, Argerie
Stevens, Bonnie
Ungar, Wendy J.
McKeever, Patricia
and
Greenberg, Mark
2011.
The cost of childhood cancer from the family's perspective: A critical review.
Pediatric Blood & Cancer,
Vol. 56,
Issue. 5,
p.
707.
Ungar, Wendy J.
2011.
Challenges in Health State Valuation in Paediatric Economic Evaluation.
PharmacoEconomics,
Vol. 29,
Issue. 8,
p.
641.
Kromm, Seija K.
Bethell, Jennifer
Kraglund, Ferne
Edwards, Sarah A.
Laporte, Audrey
Coyte, Peter C.
and
Ungar, Wendy J.
2012.
Characteristics and quality of pediatric cost-utility analyses.
Quality of Life Research,
Vol. 21,
Issue. 8,
p.
1315.
Langer, Astrid
Holle, Rolf
and
John, Jürgen
2012.
Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.
BMC Health Services Research,
Vol. 12,
Issue. 1,
GAUVREAU, CINDY LOW
UNGAR, WENDY J.
KÖHLER, JILLIAN CLARE
and
ZLOTKIN, STANLEY
2012.
The Use of Cost‐Effectiveness Analysis for Pediatric Immunization in Developing Countries.
The Milbank Quarterly,
Vol. 90,
Issue. 4,
p.
762.
John, Jürgen
Wolfenstetter, Silke B.
and
Wenig, Christina M.
2012.
An economic perspective on childhood obesity: Recent findings on cost of illness and cost effectiveness of interventions.
Nutrition,
Vol. 28,
Issue. 9,
p.
829.
Hutter, Maria-Florencia
Rodríguez-Ibeas, Roberto
and
Antonanzas, Fernando
2014.
Methodological reviews of economic evaluations in health care: what do they target?.
The European Journal of Health Economics,
Vol. 15,
Issue. 8,
p.
829.
Petrou, Stavros
Boland, Angela
Khan, Kamran
Powell, Colin
Kolamunnage-Dona, Ruwanthi
Lowe, John
Doull, Iolo
Hood, Kerry
and
Williamson, Paula
2014.
ECONOMIC EVALUATION OF NEBULIZED MAGNESIUM SULPHATE IN ACUTE SEVERE ASTHMA IN CHILDREN.
International Journal of Technology Assessment in Health Care,
Vol. 30,
Issue. 4,
p.
354.
Prinja, Shankar
Nandi, Arindam
Horton, Susan
Levin, Carol
and
Laxminarayan, Ramanan
2015.
Disease Control Priorities, Third Edition (Volume 1): Essential Surgery.
p.
317.
Korber, Katharina
2015.
Quality assessment of economic evaluations of health promotion programs for children and adolescents—a systematic review using the example of physical activity.
Health Economics Review,
Vol. 5,
Issue. 1,
Sullivan, Shannon M.
Tsiplova, Kate
and
Ungar, Wendy J.
2016.
A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 16,
Issue. 5,
p.
599.
Chapel, John M
and
Wang, Guijing
2019.
Understanding cost data collection tools to improve economic evaluations of health interventions.
Stroke and Vascular Neurology,
Vol. 4,
Issue. 4,
p.
214.